A mimicking esophageal cancer after liver transplant for hepatocellular carcinoma: A rare posttransplant metastasis

Jian Xun Chen, Long Bin Jeng, Yu Sen Lin, Ting Yu Lu, Pei Yu Kao, Hsin Yuan Fang*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

1 Scopus citations

Abstract

Liver transplant is now considered to be a successful treatment modality for early hepatocellular carcinoma. In addition, advances in immuno-suppressive therapy have greatly prolonged post-transplant survival of patients with hepatocellular carcinoma. However, both the posttransplant physiologic condition and immunosuppressive therapy affect the patient’s natural immunity, resulting in accumulating and more problematic complications. Three years after a male patient with hepatocellular carcinoma underwent living-donor liver transplant, he presented with esophageal metastasis from recurrence of hepatocellular carcinoma. This is an extremely rare complication, perhaps with an ominous prognosis, and, to the best of our knowledge, the first such case to be published in the English literature.

Original languageEnglish
Pages (from-to)571-574
Number of pages4
JournalExperimental and Clinical Transplantation
Volume14
Issue number5
DOIs
StatePublished - 10 2016
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Başkent University 2016 Printed in Turkey. All Rights Reserved.

Keywords

  • Esophageal metastasis
  • Living-donor liver transplant

Fingerprint

Dive into the research topics of 'A mimicking esophageal cancer after liver transplant for hepatocellular carcinoma: A rare posttransplant metastasis'. Together they form a unique fingerprint.

Cite this